Palisade Bio Inc PALI:NASDAQ

Last Price$0.45NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.45 (13)
Ask (Size)$0.50 (1)
Day Low / HighN/A - N/A
Volume111.4 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/24/2022

 

Palisade Bio Inc ( NASDAQ )

Price: $0.45
Change: -0.004 (0.93%)
Volume: 111.4 K
4:00PM ET 6/24/2022
 
 

Xenetic Biosciences Inc ( NASDAQ )

Price: $0.68
Change: +0.008 (1.23%)
Volume: 21.8 K
4:00PM ET 6/24/2022
 
 

Bellicum Pharmaceuticals Inc ( NASDAQ )

Price: $1.21
Change: -0.01 (0.82%)
Volume: 8.0 K
4:00PM ET 6/24/2022
 
 

Plus Therapeutics Inc ( NASDAQ )

Price: $0.50
Change: -0.03 (6.13%)
Volume: 128.9 K
4:00PM ET 6/24/2022
 
 

NovaBay Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $0.22
Change: +0.01 (4.61%)
Volume: 554.3 K
8:00PM ET 6/24/2022
 

Read more news Recent News

-- Earnings Flash (PALI) PALISADEBIO Posts Q1 Loss $-0.26
9:00AM ET 5/13/2022 MT Newswires

...

Palisade Bio to Launch $2 Million Registered Direct Offering; Shares Tumble Early
9:39AM ET 5/06/2022 MT Newswires

Palisade Bio (PALI) said Friday that it will launch a registered direct offering of 3,646,690 of its shares at $0.55 each for gross proceeds of about $2...

Palisade Bio Gets FDA Nod to Phase 3 Study to Accelerate Bowel Function After Surgery; Shares Surge Pre-Bell
8:57AM ET 3/22/2022 MT Newswires

Palisade Bio (PALI) said Tuesday it received a letter from the US Food and Drug Administration that paves the way for a phase 3 clinical trial to evaluate...

Palisade Bio Files $100 Million Mixed Shelf
3:30AM ET 3/21/2022 MT Newswires

Palisade Bio (PALI) on Friday filed a shelf registration statement for the potential sale of up to $100 million of its securities from time to time. The...

View all Commentary and Analysis

Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund
11:11AM ET 5/08/2022 Seeking Alpha

Palisade Bio: Guarding Intestinal Integrity
4:55AM ET 11/07/2021 Seeking Alpha

Company Profile

Business DescriptionPalisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA. View company web site for more details
Address5800 Armada Drive
Carlsbad, California 92008
Phone+1.858.704.4900
Number of Employees6
Recent SEC Filing06/23/2022EFFECT
Chief Executive Officer & DirectorThomas M. Hallam
Senior VP-Operations & Strategic DevelopmentRobert McRae
Chief Financial OfficerJ. D. Finley
Finance Director & ControllerRyker Willie

Company Highlights

Price Open$0.49
Previous Close$0.45
52 Week Range$0.40 - 4.57
Market Capitalization$9.8 M
Shares Outstanding21.9 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/23/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$4.74
Beta vs. S&P 500N/A
Revenue$260.0 K
Net Profit MarginN/A
Return on Equity-1,794.66%

Analyst Ratings as of 02/01/2022

Buy
2
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset